Cargando…

Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers

As in other fields, chronotherapy applied to arterial hypertension (AHT) may have implications on oxidative stress. We compared the levels of some redox markers between hypertensive patients with morning and bedtime use of renin-angiotensin-aldosterone system (RAAS) blockers. This was an observation...

Descripción completa

Detalles Bibliográficos
Autores principales: Vazquez-Agra, Nestor, Marques-Afonso, Ana-Teresa, Cruces-Sande, Anton, Mendez-Alvarez, Estefania, Soto-Otero, Ramon, Lopez-Paz, Jose-Enrique, Pose-Reino, Antonio, Hermida-Ameijeiras, Alvaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135118/
https://www.ncbi.nlm.nih.gov/pubmed/37107177
http://dx.doi.org/10.3390/antiox12040802
_version_ 1785031900348284928
author Vazquez-Agra, Nestor
Marques-Afonso, Ana-Teresa
Cruces-Sande, Anton
Mendez-Alvarez, Estefania
Soto-Otero, Ramon
Lopez-Paz, Jose-Enrique
Pose-Reino, Antonio
Hermida-Ameijeiras, Alvaro
author_facet Vazquez-Agra, Nestor
Marques-Afonso, Ana-Teresa
Cruces-Sande, Anton
Mendez-Alvarez, Estefania
Soto-Otero, Ramon
Lopez-Paz, Jose-Enrique
Pose-Reino, Antonio
Hermida-Ameijeiras, Alvaro
author_sort Vazquez-Agra, Nestor
collection PubMed
description As in other fields, chronotherapy applied to arterial hypertension (AHT) may have implications on oxidative stress. We compared the levels of some redox markers between hypertensive patients with morning and bedtime use of renin-angiotensin-aldosterone system (RAAS) blockers. This was an observational study that included patients older than 18 years with a diagnosis of essential AHT. Blood pressure (BP) figures were measured using twenty-four-hour ambulatory BP monitoring (24-h ABPM). Lipid peroxidation and protein oxidation were assessed using the thiobarbituric acid reactive substances (TBARS) and reduced thiols assays. We recruited 70 patients with a median age of 54 years, of whom 38 (54%) were women. In hypertensive patients with bedtime use of RAAS blockers, reduced thiol levels showed a positive correlation with nocturnal diastolic BP decrease. TBARS levels were associated with bedtime use of RAAS blockers in dipper and non-dipper hypertensive patients. In non-dipper patients, bedtime use of RAAS blockers was also associated with a decrease in nocturnal diastolic BP. Chronotherapy applied to bedtime use of some BP-lowering drugs in hypertensive patients may be linked to a better redox profile.
format Online
Article
Text
id pubmed-10135118
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101351182023-04-28 Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers Vazquez-Agra, Nestor Marques-Afonso, Ana-Teresa Cruces-Sande, Anton Mendez-Alvarez, Estefania Soto-Otero, Ramon Lopez-Paz, Jose-Enrique Pose-Reino, Antonio Hermida-Ameijeiras, Alvaro Antioxidants (Basel) Article As in other fields, chronotherapy applied to arterial hypertension (AHT) may have implications on oxidative stress. We compared the levels of some redox markers between hypertensive patients with morning and bedtime use of renin-angiotensin-aldosterone system (RAAS) blockers. This was an observational study that included patients older than 18 years with a diagnosis of essential AHT. Blood pressure (BP) figures were measured using twenty-four-hour ambulatory BP monitoring (24-h ABPM). Lipid peroxidation and protein oxidation were assessed using the thiobarbituric acid reactive substances (TBARS) and reduced thiols assays. We recruited 70 patients with a median age of 54 years, of whom 38 (54%) were women. In hypertensive patients with bedtime use of RAAS blockers, reduced thiol levels showed a positive correlation with nocturnal diastolic BP decrease. TBARS levels were associated with bedtime use of RAAS blockers in dipper and non-dipper hypertensive patients. In non-dipper patients, bedtime use of RAAS blockers was also associated with a decrease in nocturnal diastolic BP. Chronotherapy applied to bedtime use of some BP-lowering drugs in hypertensive patients may be linked to a better redox profile. MDPI 2023-03-25 /pmc/articles/PMC10135118/ /pubmed/37107177 http://dx.doi.org/10.3390/antiox12040802 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Vazquez-Agra, Nestor
Marques-Afonso, Ana-Teresa
Cruces-Sande, Anton
Mendez-Alvarez, Estefania
Soto-Otero, Ramon
Lopez-Paz, Jose-Enrique
Pose-Reino, Antonio
Hermida-Ameijeiras, Alvaro
Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers
title Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers
title_full Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers
title_fullStr Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers
title_full_unstemmed Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers
title_short Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers
title_sort assessment of oxidative stress markers in hypertensive patients under the use of renin-angiotensin-aldosterone blockers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135118/
https://www.ncbi.nlm.nih.gov/pubmed/37107177
http://dx.doi.org/10.3390/antiox12040802
work_keys_str_mv AT vazquezagranestor assessmentofoxidativestressmarkersinhypertensivepatientsundertheuseofreninangiotensinaldosteroneblockers
AT marquesafonsoanateresa assessmentofoxidativestressmarkersinhypertensivepatientsundertheuseofreninangiotensinaldosteroneblockers
AT crucessandeanton assessmentofoxidativestressmarkersinhypertensivepatientsundertheuseofreninangiotensinaldosteroneblockers
AT mendezalvarezestefania assessmentofoxidativestressmarkersinhypertensivepatientsundertheuseofreninangiotensinaldosteroneblockers
AT sotooteroramon assessmentofoxidativestressmarkersinhypertensivepatientsundertheuseofreninangiotensinaldosteroneblockers
AT lopezpazjoseenrique assessmentofoxidativestressmarkersinhypertensivepatientsundertheuseofreninangiotensinaldosteroneblockers
AT posereinoantonio assessmentofoxidativestressmarkersinhypertensivepatientsundertheuseofreninangiotensinaldosteroneblockers
AT hermidaameijeirasalvaro assessmentofoxidativestressmarkersinhypertensivepatientsundertheuseofreninangiotensinaldosteroneblockers